source
- SK pharmteco commits over $200 million to expand CDMO infrastructure, adding 100 jobs over five yearsSK pharmteco announced a plan to invest at least $200 million in building out its development and manufacturing infrastructure over the next five years. The funding is aimed at expanding the compa…
- Swedish biotech AnaCardio secures $70.9M Series B to advance heart failure drugSwedish biotech AnaCardio announced a Series B financing round that raised €62.5 million ($70.9 million). The capital will be used to move its chronic advanced heart failure drug toward registrati…